No recorded roll-call vote on this bill yet
The ROTOR Act directs the Director of the Defense Health Agency to conduct a two-phase study on cancer prevalence and mortality among military rotary-wing pilots and aviation support personnel who served on or after February 28, 1961. The study will compare cancer rates in this group to the general population and investigate potential causes.
Sec. 2, Study on cancer among military rotary-wing personnel: The study has two phases. The first phase, to be completed within one year, will determine if there is an increased prevalence or mortality rate for 12 specified cancers (brain, breast, colon/rectal, kidney, lung, melanoma, non-Hodgkin's lymphoma, ovarian, pancreatic, prostate, testicular, and urinary bladder) among covered individuals compared to the general population. If an increase is found, the second phase will identify carcinogenic toxins or hazardous materials associated with operating military rotary-wing aircraft, operating environments with excess non-ionizing radiation exposure, and potential exposures from other military service (like burn pits or contaminated water). Reports on each phase's findings must be submitted to congressional committees. Data will come from the Surveillance, Epidemiology, and End Results program and other relevant studies, and will be formatted to be consistent with that program, disaggregated by race, gender, and age.
Summary of the bill text as introduced in House (Jul 23, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.
No amendments offered
No cost estimate or committee report yet
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.